Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,966 public trials 2,023 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00020800

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Walter Reed Army Medical Center Washington D.C., District of Columbia, United States

View all 18 locations

View Trial Details

Completed

Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function

NCT00118170

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +83 more
Locations: Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States

View Trial Details

Completed

Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases

NCT00357708

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +33 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00027560

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00022581

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations: Cancer and Leukemia Group B (CALGB) Research Base Chicago, Illinois, United States

View Trial Details

Completed

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma

NCT00124605

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00253578

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Improve the Survival Rate of Chinese Children and Adolescents With Non-Hodgkin's Lymphoma

NCT01761500

Conditions: Childhood Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia

NCT00142181

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Beth Isreal Deaconness Medical Center Boston, Massachusetts, United States

Dana-farber Cancer Insitiute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy

NCT00165438

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +7 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions